GLAAD reported on Thursday that most Americans say they have not seen stories about people living with HIV in the media. In ...

For the past four decades, oral antiretroviral therapy for HIV has required daily doses. Long-acting injectable cabotegravir ...

Gilead's HIV franchise gains momentum as Yeztugo ramps up, Biktarvy leads treatment and new pipeline advances strengthen growth prospects.

Tuberculosis (TB) is responsible for about a quarter of all AIDS deaths. In 2024, it was also the leading cause of death among people with HIV. This is despite TB being a preventable and curable ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. A new sequential immunization strategy shows strong promise for an HIV vaccine, a ...

Gilead's twice-yearly shot reduced HIV infections by 96% in a second large study, the company said. The data sets the stage for likely FDA approval of lenacapavir for HIV prevention. Shares rose 3% in ...

The National Agency for the Control of AIDS has warned that misinformation, stigma and sensational reporting could undermine Nigeria’s efforts to prevent new HIV infections, urging journalists and ...

Researchers have found a striking new way to potentially eliminate HIV soon after infection using a one-time combination of three therapies. In newborn nonhuman primates treated within three days of ...

The United Nations has set a goal for near universal HIV diagnosis and treatment for all by 2030. No country in Asia has hit the mark — until this year.

For years, Philip Goulder has been obsessed with a particularly captivating idea: In the hunt for an HIV cure, could children hold the answers? Starting in the mid-2010s, the University of Oxford ...

International health organisations and experts say antiretroviral therapy and medication helps people living with HIV to live ...

Opinion: Filmmaker and HIV advocate Micheal Ighodaro explains why his new TV series centers Black and brown queer lives at a ...